So much misinformation below. Stock is being heavily accumulated by non retail and others. Verify with independent party or call the company to fact check anything and everything below....great time to buy...pretty much guaranteed to triple to 5x your money..., do your DD....

Read the last 8 or so press releases and then think about what is about to happen.

Elite will continue passing trials for each drug. 7 now in development and the NDA filings and approvals will be coming in. And those working for and with and beside market makers will accumulate and then run this back to a buck...then the company will ultimately be bought...

And everyone that is paying attention knows it..

So the CEO noting that no one can stop us a few months ago...and he is correct....somehow caused the stock to run months before that? That only works if you have. a time machine so obviously claims of pump and dump is just misinformation...I am pumped though because I am going to be able to accumulate more shares then I thought I would be able to which makes me happy...I don't think I am going to make a ton of money. I know I am....

Except no one could then or now point to any actual pump... Plenty of lies told though and misinformation all over the web. Hotstocked ran like three lying articles a week. Lots of manipulation and ready for the next run...people are accumulating...

Embeda???? Lol

Coming soon every year... Its still coming soon.

Where is it then? Lol

Don't really care either way but it is pretty funny.

Rescue? Not sure about that but definitely helping patients with Parkinsons....no cure but shows to stop PD....Stege's explained this yesterday.

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=108879618

Well that is what they said bmak.

Definitely could be....anyone think that Elite's Oxy that just passed trials is going to be Actavis Oxy as agreed with Purdue.....hmmmm....lol

Yes Isradipine is about to launch and has very little competition and has also shown very promising results for treatment of Parkinson's. A second may also launch this year as well..all noted on the conference call.....MDR.

It actually looks like 2 generics may launch. Isradipine obviously.... Anyone guess the second?

Everything you just posted is 100% factually incorrect. Unless you don't consider Isradipine a generic since there won't be much competition if any. It should launch this week or next.

The other items? You posted were just incorrect.

The reality is this has been traded/manipulated down to a 110m cap or so. Ridiculously undervalued. About to launch more generics with limited competition. All trials have been and will be highly successful....simply due to the technology and foundation therein.

Plenty of cash on hand right now to do what needs to be done on Eli 200...$7m plus. 7 ADT products in development now...,market is about 8 billion dollar market and we all know there is no reason these trials won't be successful. This generic drug making essentially.

If this was a big board stock, the cap would be 300m dollars or more,...easy...

Lots of misinformation below but Couch is extremely accurate here.

Most of what you just posted is misinformation.

We know he is meeting with marketing and sales partners on the west coast.

They just quadrupled their manufacturing capacity to meet commercialization needs on the ADT product.

The first meeting with the FDA was a q&a written back and forth in preparation for the face to face. We are waiting on the FDA response now as to whether it files here in a few weeks.... Exactly as Nasrat said at Rodman.

And reveneus continue to increase with launches ...maybe two this calendar year....that means now.

The reality is this has been traded down to a 110m cap or so. Ridiculously undervalued. About to launch more generics with limited competition. All trials have been and will be highly successful....simply due to the technology and foundation therein.

Plenty of cash on hand right now. 7 ADT products in development now...,market is about 8 billion dollar market and we all know there is no reason these trials won't be successful. This generic drug making essentially.

If this was a big board stock, the cap would be 300m dollars or more,...easy

Oxycontin is the first drug....something like 3 billion in sales

There is a serious amount of misinformation today. To clear up these items....simply listen to the CC.

Elite is going to get approvals and pretty much everyone knows it at this point.

Here is the link to the CC replay

http://www.elitepharma.com/investor_relations.asp?goto=389

In the context of what I wrote that makes zero sense and obviously says i said something I didnt. Anyway once again it is obvious and proven here over and over that nothing has been presented to indicate a efficacy trial will be required and nothing presented to indicate a reason to fear one either.

Another interesting factoid is that they still will not have a run a trial. Camargo is handling that. So your point is moot. LOL LOL

So there is nothing to fear if there is an efficacy trial required except that the leader in the field operating in 26 countries somehow screws up a generic opioid trial?

That's it? Randomization, variability, blinding issues? Again nothing to do with Elites tech which is pretty straight forward and already proven to work.

Not to mention the leader in this area Camargo is running this deal. So fearing Camargo might screw up the trial of a generic opioid is pretty unlikely to be of trouble to me.

Again this is a pharma stock. So if that is all there is to fear regarding a generic drug trial(elite has about 20 approved now) I know I am going to make a ton of money. Heck just the run up alone will take this to a dollar.

If there is no reason that it would fail then what do I really care? The company has plenty of cash and the trial as noted by Nasrat would delay filing a few months if it needed to happen at all....

The point of investing in a company is whether or not they will be successful. And based on Elites tech there is no reason they won't be and if they are, investors here will make 10x their investment if the company doesn't get bought out for less...maybe 2 bucks...and since no one can point out any reason why they won't, it seems we are all in agreement that investors here will make a ton of money.

Obviously since I just told you that Elite is the only two bead approach here. Again if there is something to fear about an efficacy trial, let's hear it.

"Wishful thinking" is trying to come up with a reason why it won't pass any and all trials on any opioid drug in existance. Again really just generic drugs. Not rocket science but very freaking smart.

You didn't answer the questions. What would be to fear from an efficacy study and again not one reason why Eli 200 won't be approved.

How many of those products have the agonist and antagonist separated? That is the dilemna the FDA is facing. It is basically two separate drugs with known effects and the Naltexone is not released unless it us crushed. So again what is to learn from an efficacy study and what would there be to fear one?

Since when do generic drugs need efficacy studies? What would be the point of an efficacy study here and how would the results be any different then what was seen in the BE trials?

And what would be to fear from an efficacy study? Opioids have relieved pain for 100 years.

If the existing drug is the same and BE to the reference as proven per trials....then you know it works. It is a generic drug. Only difference is there are naltrexone beads which do not leak.

Again if you have some data to present that indicates why it won't be approved you go ahead and share it.

There is a great quote that was posted today regarding how in the short term value of a company is not reflected in the price but in the long term it is.

This company has gone from brink of bankruptcy to a short filer with the SEC and plenty of cash on hand. Remarkable.

Thats the crazy thing. It is almost infinite up to the entire market of opioids in the country and maybe the world. It is kind of a no brainer.

If Eli 200 gets approved which there is no reason it won't then basically it is an open door for every other opiod out there. Elite will have a license to print money..... But they will get bought out long before then anyway.

Worth much more than that obviously. Since everyone is pretty much clear that there is no reason why Eli 200 will not be approved, the value should be 5-10x from where it is...really much more than that with some vision.

Also some interesting reading out there on some ph3 trials using isradipine for Parkinson's...

Isradipine is going to Launch shortly. And possibly a second this calendar year. Anyone got a feel for which one that might be?

Yes because folks are accumulating and will run the stock until the time is right just like before..,,except next time instead of .10 to .97, it will be from .30 to $3.00

And again there has been absolutely nothing presented to think oitherwise.

Wow. Almost everything just posted is false again. This is a generic drug. All trials have passed beautifully. That is how drugs get approved so saying there is no reason is opposite how it works. There is every reason and everyone here knows it.

The company is basically profitable and growing outside of R&D so you posted more false information there...

Share count is pretty low really and they have plenty of cash.

And did we forget Nasrat buying almost another 1m shares on the open market?

Richme,

Since no one can provide the answer..,is there any reason why Elite's ELI 200 will not be approved? The rest of what posted at least from what I could understand is false. I see very little conversation about the product and trials and pending submission. Everyone knows this product is going to approved.

And no one can give a reason why it will not.

Actually he said basically the same things he said yesterday at Rodman and at the last quarterly call.

Yes. They have to let the FDA confirm that nothing else is needed. That is common sense born out of experience. Since we don't know for sure whatnth FDA will say....you can't be sure.,,,again doesn't matter since the products are really just generic drugs so any efficacy trial is really just going through the motions.

I think everything you have posted is incorrect. Infinite delays? I am unaware of any delays.

Yeah you are. I think everyone knows it. If there was a reason why these drugs do bnotnget approved....there would be people yelling it. On some other srocksni own and follow the arguments are often about the actual drug and viability. There is no reason I have seen that this will not be approved.

Present them

Great CC. There really are no valid arguments against approval. And actually we are just waiting on the FDA to make a decision as to whether we need another study or not. As Nasrat noted there really is not another drug out there like it.

Nope. Nobody claimed VNDM was not selling. You claimed dilutive shares. See how you tried to change the subject there?

And miktrader tried claiming VNDM on the ask and it isn't IRs shares they were selling. Not course VNDM has rarely been on the ask and no reason to think IR is selling shares.

Now is VNDM and VFIN been on level2? Sure along with 10 other MMs...on the bid too and very rarely on thenimmediate ask. but this is your typical scare tactic by shorts that need to cover.... And anyone can sell through VNDM....anyone...

Miktrader tried this tactic and got hosed...read the msg history.

Not sure I didn't or I even know the answer. I have bought and sold a decent number of times at different prices and acquired a nice long position. I could stand to add some more I suppose. Thinking about it.